Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Bringing androgens up a NOTCH in breast cancer.

Tarulli GA, Butler LM, Tilley WD, Hickey TE.

Endocr Relat Cancer. 2014 Aug;21(4):T183-202. doi: 10.1530/ERC-14-0248. Epub 2014 Jul 7. Review.

2.

Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids.

Hackenberg R, Schulz KD.

J Steroid Biochem Mol Biol. 1996 Jan;56(1-6 Spec No):113-7. Review.

PMID:
8603031
3.

[Dual effects of androgens on mammary gland].

Brettes JP, Mathelin C.

Bull Cancer. 2008 May;95(5):495-502. doi: 10.1684/bdc.2008.0631. Review. French.

4.

Complexities of androgen receptor signalling in breast cancer.

McNamara KM, Moore NL, Hickey TE, Sasano H, Tilley WD.

Endocr Relat Cancer. 2014 Aug;21(4):T161-81. doi: 10.1530/ERC-14-0243. Epub 2014 Jun 20. Review.

5.

Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.

Hanamura T, Niwa T, Nishikawa S, Konno H, Gohno T, Tazawa C, Kobayashi Y, Kurosumi M, Takei H, Yamaguchi Y, Ito K, Hayashi S.

Breast Cancer Res Treat. 2013 Jun;139(3):731-40. doi: 10.1007/s10549-013-2595-x. Epub 2013 Jun 19.

PMID:
23780684
6.

Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.

Hoffmann J, Sommer A.

J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):191-200. Epub 2005 Jan 28.

PMID:
15860262
7.

Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?

Hickey TE, Robinson JL, Carroll JS, Tilley WD.

Mol Endocrinol. 2012 Aug;26(8):1252-67. doi: 10.1210/me.2012-1107. Epub 2012 Jun 28. Review.

8.

Conjugated and non-conjugated androgens differentially modulate specific early gene transcription in breast cancer in a cell-specific manner.

Notas G, Pelekanou V, Castanas E, Kampa M.

Steroids. 2010 Aug-Sep;75(8-9):611-8. doi: 10.1016/j.steroids.2009.10.004. Epub 2009 Oct 24.

PMID:
19857505
9.

Androgens induce divergent proliferative responses in human breast cancer cell lines.

Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ, Tilley WD.

J Steroid Biochem Mol Biol. 1995 May;52(5):459-67.

PMID:
7748811
10.

Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory.

Nahleh Z.

Future Oncol. 2008 Feb;4(1):15-21. doi: 10.2217/14796694.4.1.15. Review.

PMID:
18240997
11.

Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.

Vis AN, Schröder FH.

BJU Int. 2009 Aug;104(4):438-48. doi: 10.1111/j.1464-410X.2009.08695.x. Epub 2009 Jun 24. Review.

12.

Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer.

Ormandy CJ, Hall RE, Manning DL, Robertson JF, Blamey RW, Kelly PA, Nicholson RI, Sutherland RL.

J Clin Endocrinol Metab. 1997 Nov;82(11):3692-9.

PMID:
9360527
13.

DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation.

Lanzino M, Maris P, Sirianni R, Barone I, Casaburi I, Chimento A, Giordano C, Morelli C, Sisci D, Rizza P, Bonofiglio D, Catalano S, Andò S.

Cell Death Dis. 2013 Jul 11;4:e724. doi: 10.1038/cddis.2013.235.

14.

Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.

Dai JL, Maiorino CA, Gkonos PJ, Burnstein KL.

Steroids. 1996 Sep;61(9):531-9.

PMID:
8883219
15.

Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo.

Ochnik AM, Moore NL, Jankovic-Karasoulos T, Bianco-Miotto T, Ryan NK, Thomas MR, Birrell SN, Butler LM, Tilley WD, Hickey TE.

Menopause. 2014 Jan;21(1):79-88. doi: 10.1097/GME.0b013e3182936ef4.

PMID:
23715406
16.
17.

Influence of stromal-epithelial interactions on androgen action.

Nieto CM, Rider LC, Cramer SD.

Endocr Relat Cancer. 2014 Aug;21(4):T147-60. doi: 10.1530/ERC-14-0138. Epub 2014 May 28. Review.

18.

Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner.

Ray S, Johnston R, Campbell DC, Nugent S, McDade SS, Waugh D, Panov KI.

Gene. 2013 Aug 15;526(1):46-53. doi: 10.1016/j.gene.2013.04.018. Epub 2013 Apr 19.

PMID:
23608168
19.
20.

Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines.

Marques RB, Dits NF, Erkens-Schulze S, van Ijcken WF, van Weerden WM, Jenster G.

PLoS One. 2011;6(8):e23144. doi: 10.1371/journal.pone.0023144. Epub 2011 Aug 4.

Supplemental Content

Support Center